Xenon Pharmaceuticals Inc.

NASDAQ:XENE

40.09 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q3
Revenue 005.380000.0090.1320.5368.7663.7378.1242.2184.3585.156.55413.3847.0783.3293.50060000.0160.2640.0150.0160.3760.4130.4130.6013.2274.2944.0464.014.87813.1935.2985.0015.58310.7885.4935.4933.0493.049
Cost of Revenue 0.6590.5990.8511.7340.6020.3540.51529.43122.14619.3621.88718.89118.37716.30814.96713.04510.7211.79111.7529.7518.2059.1376.40265.4165.5686.3977.1646.1095.9030.0080.4910.3420.2890.5680.6220.7090.8631.0381.761.6291.4761.8061.4751.4651.4652.0722.072
Gross Profit -0.659-0.5994.529-1.734-0.602-0.354-0.506-29.299-21.61-10.594-18.15-10.767-16.159-11.95-9.817-6.4912.664-4.713-8.423-6.251-8.205-9.137-0.402-6-5.416-5.568-6.381-6.9-6.094-5.8870.368-0.0780.0710.3122.6593.6723.3373.1473.8411.4333.6693.5253.7779.3134.0284.0280.9770.977
Gross Profit Ratio 000.842000-57.75-221.962-40.317-1.209-4.857-1.325-7.285-2.742-1.906-0.990.199-0.666-2.53-1.78600-0.067000-398.813-26.136-406.267-367.9380.979-0.1890.1720.5190.8240.8550.8250.7850.7870.8670.6930.7050.6770.8630.7330.7330.320.32
Reseach & Development Expenses 49.70244.2541.07642.8844.0439.51634.8329.43122.14619.3621.88718.89118.37716.30814.96713.04510.7211.79111.7529.7518.2059.1376.4066.245.4085.586.3977.1646.1095.9034.3965.9655.1034.3644.2633.7933.6693.4273.4533.2162.5662.5332.7432.5773.4923.4922.8432.843
General & Administrative Expenses 19.40214.79112.61912.80411.5849.5358.5018.8298.7056.7756.6884.8316.3394.1093.1063.2083.313.323.1752.72.3072.6212.0281.9382.1782.2381.671.7441.7992.11.4421.7791.6761.8951.5671.3210.1781.7891.391.3161.3541.4360.8211.6921.4141.4141.7231.723
Selling & Marketing Expenses -0.659-0.599-0.851000000000000000000000000000000000000000000000
SG&A 18.74314.19211.76812.80411.5849.5358.5018.8298.7056.7756.6884.8316.3394.1093.1063.2083.313.323.1752.72.3072.6212.0281.9382.1782.2381.671.7441.7992.11.4421.7791.6761.8951.5671.3210.1781.7891.391.3161.3541.4360.8211.6921.4141.4141.7231.723
Other Expenses 00-15.0087.0657.94307.0750000000000.432000000004.39800000000000.96900000000000
Operating Expenses 68.44558.44252.84455.68455.62449.05143.33138.2630.85126.13528.57523.72224.71620.41718.07316.25314.0315.11114.92712.45110.51211.7588.4348.1787.5867.8188.0678.9087.9088.0035.8387.7446.7796.2595.835.1143.8475.2164.8434.5323.923.9693.5644.2692.4752.4752.4232.423
Operating Income -69.104-59.041-53.695-55.684-55.624-49.051-43.331-38.128-30.315-17.369-24.838-15.598-22.498-16.059-12.923-9.699-0.646-8.033-11.598-8.951-10.512-11.758-8.434-14.178-7.586-7.818-8.051-8.644-7.893-7.987-5.462-7.331-6.366-5.658-2.603-0.820.199-1.2060.0358.6611.3781.0322.0196.5190.5870.587-1.516-1.516
Operating Income Ratio 00-9.98000-4,943.076-288.848-56.558-1.981-6.647-1.92-10.143-3.685-2.509-1.48-0.048-1.135-3.484-2.55700-1.406000-503.188-32.742-526.2-499.188-14.527-17.751-15.414-9.414-0.807-0.1910.049-0.3010.0070.6560.260.2060.3620.6040.1070.107-0.497-0.497
Total Other Income Expenses Net 10.84711.5228.7477.0657.9437.6147.0750.391-1.699-2.695-0.505-0.1280.1170.1550.4970.4750.432-0.2380.097-0.080.1350.13-0.4250.148-0.144.114-0.1090.7780.4040.321-0.71-0.4970.2272.296-1.431-3.1370.969-3.1711.0370.392-0.2850.20.358-0.2430.9830.9830.0910.091
Income Before Tax -58.257-47.519-44.948-48.619-47.681-41.437-36.256-37.737-31.198-20.064-25.08-15.65-22.326-15.832-12.337-9.058-0.214-7.485-11.412-8.866-10.036-11.304-8.558-14.383-7.801-3.755-8.065-7.742-7.38-7.517-6.004-7.714-6.016-3.263-3.937-3.8271.168-4.2251.2249.1911.231.3732.5146.3781.571.57-1.425-1.425
Income Before Tax Ratio 00-8.355000-4,135.98-285.886-58.205-2.289-6.711-1.926-10.066-3.633-2.396-1.382-0.016-1.058-3.428-2.53300-1.426000-504.063-29.326-492-469.813-15.968-18.678-14.567-5.429-1.22-0.8910.289-1.0540.2510.6970.2320.2750.450.5910.2860.286-0.467-0.467
Income Tax Expense -0.3330.412-0.205-0.157-0.220.291.139-0.587-0.04-0.3940.484-0.205-0.217-0.068-0.014-0.203-0.039-0.001-0.0360.005-0.0290.0370.3570.6780.20.1590.014-0.902-0.513-0.470.5420.383-0.35-2.3951.3343.007-0.2853.019000.148-0.3410.0080.0151.571.5700
Net Income -57.924-47.931-44.743-48.462-47.461-41.727-37.395-37.15-31.158-19.67-25.564-15.445-22.109-15.764-12.323-8.855-0.175-7.484-11.376-8.871-10.007-11.341-8.558-14.383-7.801-3.755-8.065-7.742-7.38-7.517-6.004-7.714-6.016-3.263-3.937-3.8271.168-4.2251.2249.1911.231.3732.5146.37800-1.425-1.425
Net Income Ratio 00-8.317000-4,265.914-281.439-58.131-2.244-6.841-1.901-9.968-3.617-2.393-1.351-0.013-1.057-3.417-2.53500-1.426000-504.063-29.326-492-469.813-15.968-18.678-14.567-5.429-1.22-0.8910.289-1.0540.2510.6970.2320.2750.450.59100-0.467-0.467
EPS -0.75-0.62-0.64-0.73-0.72-0.63-0.57-0.59-0.55-0.37-0.62-0.37-0.53-0.43-0.35-0.25-0.005-0.23-0.34-0.34-0.39-0.44-0.34-0.71-0.55-0.22-0.45-0.43-0.41-0.42-0.33-0.51-0.42-0.23-0.27-0.270.08-0.30.0860.260.140.150.280.9900-1.07-1.07
EPS Diluted -0.75-0.62-0.64-0.73-0.72-0.63-0.57-0.57-0.55-0.36-0.62-0.37-0.53-0.43-0.33-0.25-0.005-0.23-0.34-0.34-0.39-0.44-0.33-0.71-0.55-0.21-0.45-0.43-0.41-0.42-0.33-0.51-0.42-0.23-0.27-0.27-0.07-0.30.0860.260.130.140.260.6300-1.07-1.07
EBITDA -68.445-58.442-52.844-55.684-55.624-50.888-43.331-35.095-28.241-13.93-24.305-15.313-22.212-15.791-12.632-9.362-0.646-6.813-11.015-8.319-9.706-10.997-7.635-13.71-7.309-7.56-7.795-9.254-8.128-8.143-4.586-6.667-6.344-7.672-0.8882.5790.1992.1720.3928.9821.8381.0072.3386.7950.7730.773-1.43-1.43
EBITDA Ratio 00-9.822000-4,943.076-265.871-52.688-1.589-6.504-1.885-10.014-3.623-2.453-1.428-0.048-0.963-3.309-2.37700-1.273000-487.188-35.053-541.867-508.938-12.197-16.143-15.361-12.765-0.2750.6010.0490.5420.080.6810.3470.2010.4190.630.1410.141-0.469-0.469